RPL7P55: A Promising Drug Target / Biomarker (G100271147)

Target Name: RPL7P55

NCBI ID: G100271147

RPL7P55

Other Name(s): RPL7_32_1793 | Ribosomal protein L7 pseudogene 55 | ribosomal protein L7 pseudogene 55

RPL7P55: A Promising Drug Target / Biomarker

RPL7P55 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the P-type cation transporter (P-CT) family, which is a family of transmembrane proteins that play an important role in the transport of various types of ions and molecules across cell membranes. P-CT proteins are characterized by their ability to import cations, such as calcium, magnesium, and potassium, into the cytosol of the cell.

The discovery and characterization of RPL7P55

RPL7P55 was first identified as a new gene in the database using a combination of genomic and transcriptomic approaches. The gene was named based on its unique 55 amino acid coding sequence, which is unusual for a protein of its size. Subsequent studies have shown that RPL7P55 is a member of the P-CT family and is expressed in a variety of tissues, including the brain, heart, and liver.

Function and localization

RPL7P55 is a cytoplasmic protein that is primarily localized to the cytosol of the cell. It is also expressed in the endoplasmic reticulum (ER) and has been shown to be involved in the import of calcium ions into the cytosol. This is consistent with its function as a P-CT protein, which is characterized by its ability to import cations into the cytosol of the cell.

Expression and regulation

RPL7P55 is expressed in a variety of tissues and cells and has been shown to be involved in a number of cellular processes. It is highly expressed in the brain, where it is involved in the regulation of neural signaling and memory. It is also expressed in the heart and is thought to be involved in the regulation of contractility and heart rate. In addition, RPL7P55 is expressed in the liver and is involved in the regulation of metabolism and inflammation.

Drug targeting

Due to its unique function and its expression in various tissues, RPL7P55 has been identified as a potential drug target. Studies have shown that RPL7P55 is targeted by a number of drugs, including inhibitors of its import function and modulators of its expression level. For example, inhibitors of RPL7P55 have been shown to reduce the amount of calcium ions in the cytosol of the cell, which is consistent with its function as a P-CT protein. Similarly, modulators of RPL7P55 expression have been shown to alter the levels of the protein in the cell.

Conclusion

RPL7P55 is a protein that is expressed in various tissues of the body and is involved in the regulation of various cellular processes. Its unique function as a P-CT protein and its expression in various tissues make it a potential drug target. Further research is needed to fully understand the role of RPL7P55 in cellular processes and to develop effective treatments for its associated diseases.

Protein Name: Ribosomal Protein L7 Pseudogene 55

The "RPL7P55 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL7P55 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets